Considerations on inhibition of IL-23 in psoriatic women of childbearing potential.

Roberto RussoGiulia GaspariniEmanuele Cozzani Martina BurlandoAurora Parodi

Published in: Dermatologic therapy (2021)

Lack of safety data on pregnant women determines difficulty in choosing the correct biologic agent to treat psoriasis in women of childbearing potential. Studies have postulated a role of IL-23 in unexplained recurrent spontaneous abortions. This gives rise to consideration about use of anti-IL-23 drugs in treatment of psoriasis in women of childbearing potential.

Keyphrases

polycystic ovary syndrome
pregnant women
pregnancy outcomes
rheumatoid arthritis
human health
big data
metabolic syndrome
risk assessment
artificial intelligence